GLP-1 Use Impacts Declining Obesity Rate
Are Americans more obsessed with weight loss than other cultures? Well, maybe we should be. The obesity statistics are scary. That said, could the obesity rate be on the decline? A...
Search fresh public links, source activity, and post angles for Glp-1 Use Impacts Declining Obesity Rate.
Fresh curated links around GLP-1 Use Impacts Declining Obesity Rate are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
Are Americans more obsessed with weight loss than other cultures? Well, maybe we should be. The obesity statistics are scary. That said, could the obesity rate be on the decline? A...
A pair of trial results published in medical journals suggest switching from high-dose injectables to lower doses or pills could help people with obesity keep their weight down ove...
WEDNESDAY, May 6, 2026 — The number of weight-loss surgery procedures in the United States is dropping rapidly in the face of cutting-edge drugs like Ozempic and Zepbound, a new st...
*Metabolic and bariatric surgeries in the United States have seen a notable decline in recent years, even as GLP-1 medications continue to gain traction as a treatment option for o...
The growing adoption of GLP-1 medications has already begun to transform society and industry sectors, along with helping many patients effectively deal with managing diabetes and...
WEDNESDAY, May 27, 2026 — A new study suggests GLP-1 medications may slow the spread of certain obesity-related cancers. "GLP-1 receptor agonists have never been just glucose-lower...
New research indicates that maintaining meaningful weight loss after starting GLP-1-based therapies could play an important role in reducing the risk of multiple obesity-related di...
Weight loss culture is shifting again. In recent years, the dominant aesthetic ideal emphasized curves and the “Kardashian-curve” look popularized across social media. Today, the p...
New research presented at this year's European Congress on Obesity in Istanbul, Turkey (12-15 May) shows the use of the new GLP-1 class of obesity drugs in people with asthma is as...
At least 1 in 5 U.S. households now has a GLP-1 user — and it's quietly shrinking grocery bills, reshaping restaurant spending, and driving a clothing buying spree.
A huge international review found that GLP-1 weight-loss drugs significantly reduce the risk of heart attacks, strokes, heart failure, and premature death over the long term. Resea...
New research to be presented at this year's European Congress on Obesity (ECO 2025, Malaga, Spain, 11-14 May) shows that patients using GLP-1 or combined GLP-1 / GIP receptor agoni...
Millions of people are using or have used GLP1 drugs including Ozempic, Wegovy and Mounjaro to combat diabetes and obesity.
CHICAGO — Patients with obesity and inflammatory bowel disease showed improved bowel function while receiving GLP-1 receptor agonists and lifestyle counseling, in contrast to the g...
A simple outpatient procedure currently used for type 2 diabetes patients in Europe can help those on Eli Lilly’s obesity drug tirzepatide keep most of their weight off when stoppi...
The different medications work to help regulate appetite and blood sugar levels.
GLP-1 agonists have been a remarkable treatment for those who suffer from obesity-related illness, but suppressing hunger cues could pose a risk for those with eating disorders.
A new study found that some cancer patients who took GLP-1 drugs saw some remission — especially if they had breast cancer.
And how it compares to people not taking a GLP-1.
GLP-1 medications effectively "turn down the volume" on intrusive food thoughts. In a study of 417 adults, those combining medication with behavioral therapy saw a significantly gr...
Adults with overweight or obesity taking the new generation of weight loss drugs semaglutide and tirzepatide tend to eat significantly less, leaving them vulnerable to nutritional...
The U.S. Food and Drug Administration on Wednesday approved the second GLP-1 pill for weight loss, adding another option to a rapidly growing arsenal of obesity therapies.
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.